Sponsors

Event Organizer

ARM-Logo_250The Alliance for Regenerative Medicine (ARM) is an international multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine worldwide. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, D.C. to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today, ARM has more than 300 members and is the leading global advocacy organization in this field. www.alliancerm.org

Co-Hosts

BTIG_170x87BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 600 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. BTIG’s investment banking products include: capital markets advisory, mergers and acquisitions, IPOs, follow-on offerings, ATMs, CMPOs, RDs and PIPEs, SPACs, private placements, convertibles, debt, buybacks, liquidity solutions, venture capital, private equity and private capital. Aftermarket services include trading coverage and corporate access, connecting issuers with the buy side. BTIG delivers market strategy and fundamental equity research covering a wide universe of more than 330 established and emerging growth companies across market capitalization. www.btig.com

New Chardan LgooFounded in 2002 and headquartered in New York, Chardan is an independent, global investment bank focused on addressing the capital markets needs of public and private genetic medicines companies. Chardan focuses on companies that offer superior investment return prospects, based on the potential to create real value for society. In following vector gene therapy, small RNA therapy, and gene editing companies, Chardan covers more genetic medicines names than any other bank globally. Chardan is known for its market impact, communicating on fundamental sector value drivers (e.g. via the predictive Chardan Gene Therapy Framework), and has successfully raised more than $2.75 billion for public and private genetic medicines companies since 2015. www.chardan.com | info@chardan.com | 646-465-9018

Raymond-James_270x77As one of North America’s leading full-service investment firms, Raymond James offers a full array of capital markets services, strategic advice and planning for every stage of the business life cycle. Our focus is on remaining agile and taking a personal approach to serving the needs of growth companies and the institutional and retail communities that invest in them. Raymond James Equity Research is a cornerstone of the organization. Raymond James and its affiliates in Canada and Europe employ more than 70 research analysts who cover nearly 1,300 companies in nine highly focused industries: Consumer, Energy, Financial Services, Healthcare, Industrial, Mining and Natural Resources, Real Estate, Technology and Communications, and Transportation. We are a top provider of equity research in both North America and globally in terms of companies covered. www.raymondjames.com

Solebury_230Solebury Trout partners with private and public companies across all industries, helping management teams prepare for capital raising, access investors and tackle complex investor relations and corporate communications issues. More than 60 professionals with expertise in investor relations, equity research, portfolio management, private equity, investment banking and corporate communications work at Solebury Trout. The company was formed through the combination of Solebury Communications with the Trout Group, the premier investor relations and strategic advisory firm serving the biotechnology industry, providing corporate access and hosting dozens of well-attended conferences and thought leader events. Solebury Trout is affiliated with leading equity capital markets advisory firm Solebury Capital, which in 2017 advised on nearly 40 percent of the IPO proceeds in the U.S., and is owned by PNC, one of the largest diversified financial institutions in the country. www.soleburytrout.com

Platinum Sponsor

LPB_175x100Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life. The company is organized into two market-focused segments: Pharma and Biotech and Specialty Ingredients. The core competencies that span these segments are advanced manufacturing and quality-control systems, superior regulatory expertise, in-depth market knowledge and extensive technical customer-support and research and development capabilities. www.lonza.com

Industry Sponsors

Cognate-Bioservices_140x57Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, cGMP facilities and an international track record makes Cognate one of the most experienced contract manufacturers of cell-based products in the world today. www.cognatebioservices.com

Crossover-Search_190x57Crossover Search is a boutique search firm dedicated to the life sciences industry. Since 2008, we have partnered with a broad range of innovative pharmaceutical, biotechnology, medical device, and diagnostics companies, primarily in the U.S. and Europe. Our expertise spans the entire industry, and our track record includes successful placements in various business units, functions, and therapeutic areas. We provide professional search and recruiting services aimed at ensuring that you have the talent you need, from the lab to the boardroom, to achieve your scientific and business goals. At our core, we are a firm built on the belief that relationships are the lifeblood of our business. This goes for clients, candidates, and our team. www.crossoversearch.com

CTI_170x57CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts Phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across six continents, CTI partners with research sites, patients and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America and Asia-Pacific. www.ctifacts.com

Medpace_180x57Medpace is a global full-service Clinical Research Organization (CRO) providing comprehensive development services for drug, biologic and device programs with a specialized focus on advanced therapies including cell and gene therapies. Medpace has strong experience supporting development programs for regenerative medicine products across a number of therapeutic areas including cardiovascular, neuroscience, musculoskeletal and diabetes. With extensive medical expertise, a renowned regulatory affairs department, across six continents, Medpace conducts studies and navigates regulatory requirements worldwide. From feasibility, research site compatibility, safety and logistics, Medpace brings efficiencies and operational excellence to regenerative medicine development programs. In addition, Medpace offers integrated imaging and lab capabilities through its family of companies to provide cohesive, streamlined and standardized trial management. Learn more about Medpace’s focus on cellular, tissue and gene therapy medicines at www.medpace.com.

Event Supporters

Edison_150_updatedEdison is an investment research, investor relations, and consulting firm with offices in North America, Europe, and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors, and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. www.edisongroup.com

PharmaIntel_190Informa Pharma Intelligence delivers the data and insights needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth. Its market leading products cover every perspective of key diseases, clinical trials, drug approvals, or R&D projects and are supported by the breadth and depth of its data and insights. www.pharmaintelligence.informa.com

By using this website you agree to accept our Privacy Policy and Terms & Conditions